000			01692nam a22002177a 4500
005			20230313120431.0
008			230302b ||||| |||| 00| 0 eng d
020			_a9789812832276
040			_cAL
041			_aeng
082			_223 _a346.048 _bDUTI
100			_aGraham Dutfield _973836
245			_aIntellectual Property Rights and the Life Science Industries _bPast Present and Future
250			_a2th ed.
260			_aLondon _bWorld Scientific _c2009
300			_axiii,410p. _bHB _c23x15cm.
365			_2General _aABDI/0658/23 _b₹6837.00 _c₹ _d₹9116.00 _e25% _f21/01/2023
520			_aThis book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to “invent” life forms from scratch.
650			_2Private law _aPrivate law _975196
942			_2ddc _cBK
999			_c226864 _d226864